7848ebcb 7a13 48a8 Bbeb 7481d040c068 01
Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 70518-0942
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 70518-0942). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
7848ebcb 7a13 48a8 Bbeb 7481d040c068 02
This is a chart depicting the concentration of Tramadol, measured in nanograms per milliliter, plotted against time in hours. The chart shows two lines, one for Tramadol Hydrochloride Extended-Release Tablets at 200mg once daily and another for Tramadol Hydrochloride Tablets at 50mg every 6 hours.*
7848ebcb 7a13 48a8 Bbeb 7481d040c068 03
This appears to be a chart showing the concentration of M1 (a metabolite of tramadol) over time, with two different types of tramadol being compared: extended-release tablets at a dose of 200mg once daily, and regular tablets at a dose of 50mg every 6 hours. The concentration of M1 is plotted on the y-axis and time is on the x-axis.*
7848ebcb 7a13 48a8 Bbeb 7481d040c068 04
This is a graph that displays the percentage of patients reaching different levels of response threshold for Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis. The graph shows four different dosages of Tramadol Hydrochloride Extended-Release Tablets (100, 200, 300, and 400 mg) and placebo. It compares the patients' achievement of various levels of response threshold. The horizontal axis shows the response threshold (percent improvement from baseline), and the vertical axis shows the percentage of patients achieving it.*
7848ebcb 7a13 48a8 Bbeb 7481d040c068 05
This is a study on Tramadol Hydrochloride Extended-Release Tablets for Arthritis Pain. The study analyzed patients achieving various levels of pain response threshold to the medication. The results are presented in a graph representing the percentage of patients achieving response threshold against the percent improvement from baseline. The graph also includes a placebo comparison.*
Tramadol HCl 100mg 70518 0942 00
This is a description of Tramadol HCI 100 mg Extended-Release tablets packaged in a quantity of 30 by Orepack. It is only available with a prescription and has an NDC number of 70518-0942-00. The manufacturer is Lupin Pharma located at Baltimore, MD 21202. The drug should be kept away from children and should only be used as directed by the package insert. The drug should not be transferred to anyone other than the intended patient as per Federal law. Store between 20-25°C (58-77°F) with excursions permitted to 15-30°C (50-86°F) [See USP]. This drug has been repackaged by RemedyRepack Ine. at Indiana, PA 15701.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
